FDA Commissioner Marty Makary named Vinay Prasad, a hematologist oncologist and critic of the Covid-19 vaccine for children, as the next director of the Center for Biologics and Research.
Prasad joins the Food and Drug Administration from the University of California at San Francisco, where he served since 2020 as an epidemiology professor. Prasad previously worked at the National Cancer Institute, where he completed a fellowship in cancer prevention and was a fellow in hematology and oncology at the National Institutes of Health.
Shares of makers of vaccines and immunotherapies plunged Tuesday after the news.
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.